Skip to content
Trial Eligibility
Menu

NIRS Monitoring in the NICU and AKI

NCT07222722

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants <30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants <30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Acute Kidney Injury (AKI)
  • Postnatal AKI

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
24 to 30 weeks
Sex
All
Healthy volunteers
Accepted
Sponsor
NYU Langone Health
Last updated on ClinicalTrials.gov
October 30, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • NYU Langone Health · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.